Skip to main content

IDWeek 2024 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

300 Views

Z11. COVID-19 Vaccines

Poster Session: COVID-19: Vaccines

(P-2056) Modelling the Relative Vaccine Effectiveness of ARCT-154 versus BNT162b2 using Immunogenicity Data

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Co-Author(s)

VN

Van Nguyen, PhD

VHN Consulting
Montreal, Quebec, Canada
PC

Pascal Crepey, n/a

Epidemiology Professor
University of Rennes
Rennes, Bretagne, France
JP

Jean Marie Pivette, n/a

Epidemiologist
VHN Consulting
Lyon, Rhone-Alpes, France
ES

Ettan Settembre, n/a

Vice President, Research
CSL Seqirus USA
Boston, Massachusetts, United States
SR

Sankarasubramanian Rajaran, n/a

Head of Global Medical Strategy
CSL Seqirus UK
Maidenhead, England, United Kingdom
JY

John Youhanna, n/a

Director Seasonal Medical Affairs
CSL Seqirus USA
Summit, New Jersey, United States
AF

Aimee Ferraro, n/a

Senior Manager CORE
CSL Seqirus USA
Summit, New Jersey, United States
CC

Cheng Chang, n/a

Lead of Research mRNA Platform
CSL Seqirus USA
Boston, Massachusetts, United States
JV

Josephine Van Boxmeer, n/a

Principal Clinical Scientist
CSL Seqirus USA
Amsterdam, Noord-Holland, Netherlands

Presenting Author(s)

Joaquin F. Mould-Quevedo, PhD

Global Health Economics and Value Strategy Senior Director
CSL Seqirus Inc.
Summit, New Jersey, United States